This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
2
Given PO
Given PO
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Effects of glucosamine sulfate/chondroitin sulfate tablet (G&C) on gut microbial community modulation
shifts in the bacterial communities within person based on clustering of operational taxonomic units (OTU) at 97% utilizing principal coordinate analysis \[PCOA\]).
Time frame: Up to 2 years
Effects of G&C on serum C-reactive protein (CRP)
evaluated using a generalized estimating equation which accounts for variation due to repeated measures within an individual
Time frame: Up to 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.